Effect of home-based pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis

Sevgi Ozalevli, Hayriye Kul Karaali, Duygu Ilgin, Eyup Sabri Ucan, Sevgi Ozalevli, Hayriye Kul Karaali, Duygu Ilgin, Eyup Sabri Ucan

Abstract

Objective: The aim of this study was to investigate the effects of a home-based pulmonary rehabilitation program on the functional outcome parameters in patients with idiopathic pulmonary fibrosis (IPF).

Design: A prospective study.

Patients: Seventeen patients diagnosed with IPF.

Methods: A home-based pulmonary rehabilitation program was carried out in 17 IPF patients for 12 weeks. Dyspnea severity during daily life activities (Medical Research Council Scale), pulmonary function (pulmonary function test), exercise capacity (6-minute walking test, 6MWD), and general health related quality of life (Medical Outcomes Short Form-36) were evaluated.

Results: A significant decrease in perceived dyspnea (p = 0.003) and leg fatigue (p < 0.05) severities, and an increase in the 6MWD (p = 0.04) and general health related quality of life scores (health perception, physical role, and emotional status subscores) were found after the program (p < 0.05).

Conclusion: Home-based pulmonary rehabilitation may reduce dyspnea and fatigue severities, and improve exercise capacity and health-related quality of life in patients with IPF. In the treatment of IPF patients, home-based pulmonary rehabilitation programs should be placed alongside the routine treatment options.

Figures

Figure 1
Figure 1
The 6-minute walking distance before and after the home-based pulmonary rehabilitation program. Definition of abbreviations: 6MWD, 6-minute walking distance; PR, pulmonary rehabilitation.
Figure 2
Figure 2
The 6-minute walking test results before and after the home-based pulmonary rehabilitation program. Definition of the abbreviations: 6MWD, 6-minute walking distance; bpm, beats per minute; HR, heart rate; PR, pulmonary rehabilitation; SpO2, peripheral oxygen saturation.

References

    1. Katzenstein AL, Myers JL. Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification. Am J Respir Crit Care Med. 1998;157:1301–1315.
    1. American Thoracic Society. Idiopathic pulmonary fibrosis; diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS) Am J Respir Crit Care Med. 2000;161:646–664.
    1. Widimsky J, Riedel M, Stanek V. Central haemodynamics during exercise in patients with restrictive pulmonary disease. Bull Eur Physiopathol Respir. 1977;13:369–379.
    1. Chang JA, Curtis JR, Patrick DL, Raghu G. Assessment of health-related quality of life in patients with interstitial lung disease. Chest. 1999;116:1175–1182. doi: 10.1378/chest.116.5.1175.
    1. Jastrzebski D, Gumola A, Gawlik R, Kozielski J. Dyspnea and quality of life in patients with pulmonary fibrosis after six weeks of respiratory rehabilitation. J Physiol Pharmacol. 2006;57(Suppl 4):139–148.
    1. Naji NA, Connor MC, Donnelly SC, McDonnell TJ. Effectiveness of pulmonary rehabilitation in restrictive lung disease. J Cardiopulm Rehabil. 2006;26:237–243. doi: 10.1097/00008483-200607000-00007.
    1. Ferreira A, Garvey C, Connors GL, Hilling L, Rigler J, Farrell S, Cayou C, Shariat C, Collard HR. Pulmonary rehabilitation in interstitial lung disease: benefits and predictors of response. Chest. 2009;135:442–447. doi: 10.1378/chest.08-1458.
    1. Nishiyama O, Kondoh Y, Kimura T, Kato K, Kataoka K, Ogawa T, Watanabe F, Arizono S, Nishimura K, Taniguchi H. Effects of pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis. Respirology. 2008;13:394–399. doi: 10.1111/j.1440-1843.2007.01205.x.
    1. Holland AE, Hill CJ, Conron M, Munro P, McDonald CF. Short term improvement in exercise capacity and symptoms following exercise training in interstitial lung disease. Thorax. 2008;63:549–554. doi: 10.1136/thx.2007.088070.
    1. Swigris JJ, Brown KK, Make BJ, Wamboldt FS. Pulmonary rehabilitation in idiopathic pulmonary fibrosis: a call for continued investigation. Respir Med. 2008;102:1675–1680. doi: 10.1016/j.rmed.2008.08.014.
    1. Ries AL, Kaplan RM, Myers R, Prewitt LM. Maintenance after pulmonary rehabilitation in chronic lung disease: a randomized trial. Am J Respir Crit Care Med. 2003;167:880–888. doi: 10.1164/rccm.200204-318OC.
    1. Maltais F, Bourbeau J, Shapiro S, Lacasse Y, Perrault H, Baltzan M, Hernandez P, Rouleau M, Julien M, Parenteau S, Paradis B, Levy RD, Camp P, Lecours R, Audet R, Hutton B, Penrod JR, Picard D, Bernard S. Chronic Obstructive Pulmonary Disease Axis of Respiratory Health Network, Fonds de recherche en santé du Québec. Effects of homebased pulmonary rehabilitation in patients with chronic obstructive pulmonary disease: a randomized trial. Ann Intern Med. 2008;16:869–878.
    1. Wijkstra PJ, Strijbos JH, Koëter GH. Home-based rehabilitation for patients with COPD: organization, effects and financial implications. Monaldi Arch Chest Dis. 2000;55:130–134.
    1. Ong KC, Wong WP, Jailani AR, Sew S, Ong YY. Effects of a pulmonary rehabilitation programme on physiologic and psychosocial outcomes in patients with chronic respiratory disorders. Ann Acad Med Singapore. 2001;30:15–21.
    1. American Thoracic Society: Standardization of spirometry, 1994 Update. Am J Respir Crit Care Med. 1995;152:1107–1136.
    1. Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999;54:581–586. doi: 10.1136/thx.54.7.581.
    1. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: Guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002;116:111–117.
    1. Mahler DA, Wells CK. Evaluation of clinical methods for rating dyspnea. Chest. 1988;93:580–586. doi: 10.1378/chest.93.3.580.
    1. Brazier JE, Harper R, Jones NM, O'Cathain A, Thomas KJ, Usherwood T, Westlake L. Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ. 1992;305:160–164. doi: 10.1136/bmj.305.6846.160.
    1. Demiral Y, Ergor G, Unal B, Akvardar Y, Kivircik B, Alptekin K. Normative data and discriminative properties of short form 36 (SF-36) in Turkish urban population. BMC Public Health. 2006;6:247. doi: 10.1186/1471-2458-6-247.
    1. Ware LB. Clinical Year in Review I: Interstitial Lung Disease, Pulmonary Vascular Disease, Pulmonary Infections, and Cardiopulmonary Exercise Testing and Pulmonary Rehabilitation. Proc Am Thorac Soc. 2009;6:487–493. doi: 10.1513/pats.200907-057TT.
    1. Spruit MA, Janssen DJ, Franssen FM, Wouters EF. Rehabilitation and palliative care in lung fibrosis. Respirology. 2009;14:781–787. doi: 10.1111/j.1440-1843.2009.01599.x.
    1. Rusanov V, Shitrit D, Fox B, Amital A, Peled N, Kramer MR. Use of the 15-steps climbing exercise oximetry test in patients with idiopathic pulmonary fibrosis. Respir Med. 2008;102:1080–1088. doi: 10.1016/j.rmed.2007.12.031.
    1. Perez RL. Interstitial lung disease: causes, treatment, and prevention. Ethn Dis. 2005;15(2 Suppl 2):S45–48.
    1. Ries AL. The importance of exercise in pulmonary rehabilitation. Clin Chest Med. 1994;15:327–337.

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren